Protective Effects of Cariporide on Endothelial Dysfunction Induced by Homocysteine

被引:13
作者
Wu, Shujin [1 ,3 ]
Gao, Xiang [1 ]
Yang, Shehua [1 ]
Liu, Liying [3 ]
Ge, Bin [1 ]
Yang, Qingshan [2 ]
机构
[1] Gan Su Prov Hosp, Dept Pharm, Lanzhou 730000, Gansu, Peoples R China
[2] Gan Su Prov Hosp, Dept Orthopaed, Lanzhou 730000, Gansu, Peoples R China
[3] Cent S Univ, Pharmaceut Coll, Dept Pharmacol, Changsha, Hunan, Peoples R China
关键词
Homocysteine; Cariporide; Endothelial dysfunction; Oxidative stress; Nuclear factor-kappa B; NA+/H+ EXCHANGER; CARDIOVASCULAR-DISEASE;
D O I
10.1159/000356318
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims: Recent studies have reported that intracellular calcium (Ca2+) mobilization is involved in homocysteine (Hcy)-induced endothelial dysfunction and the Na+/H+ exchanger (NHE) is responsible for an increase in the intracellular Ca2+ concentration in cardiovascular disease. We hypothesized that inhibition of the NHE had protective effects on Hcy-induced endothelial dysfunction. Methods: Acetylcholine-induced endothelium-dependent relaxation (EDR) and biochemical parameters were measured in the rat isolated aorta. The level of reactive oxygen species (ROS) was designed by a specific fluorescent probe. The phosphorylation of the nuclear factor-kappa B (NF-kappa B) system was studied by Western blot. Results: Cariporide significantly prevented Hcy-impaired EDR and increased nitric oxide (NO) release; endothelial NO synthase activity simultaneously decreased ROS production. We also found that cariporide blocked Hcy-induced NE-kappa B activation and inhibitor-kappa B degradation, thus inhibiting the production of tumor necrosis factor-alpha and intercellular adhesion molecule-1. Conclusions:The mechanisms of protective effects of cariporide may be related to the inhibition of NHE and the decrease in oxidative stress and inflammatory injury. (C) 2013 S. Karger AG, Basel
引用
收藏
页码:303 / 309
页数:7
相关论文
共 22 条
[11]   NHE blockade inhibits chemokine production and NF-κB activation in immunostimulated endothelial cells [J].
Németh, ZH ;
Deitch, EA ;
Lu, Q ;
Szabó, C ;
Haskó, G .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2002, 283 (02) :C396-C403
[12]   Homocysteine inhibits tumor necrosis factor-induced activation of endothelium via modulation of nuclear factor-κb activity [J].
Roth, J ;
Goebeler, M ;
Ludwig, S ;
Wagner, L ;
Kilian, K ;
Sorg, C ;
Harms, E ;
Schulze-Osthoff, K ;
Koch, HG .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2001, 1540 (02) :154-165
[13]   Na+/H+ exchanger-1: a link with atherogenesis? [J].
Sarigianni, Maria ;
Tsapas, Apostolos ;
Mikhailidis, Dimitri P. ;
Kaloyianni, Martha ;
Koliakos, George ;
Fliegel, Larry ;
Paletas, Konstantinos .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (12) :1545-1556
[14]   Na +/H + exchanger inhibitor induces vasorelaxation through nitric oxide production in endothelial cells via intracellular acidification-associated Ca2 + mobilization [J].
Sasahara, Tomoya ;
Yayama, Katsutoshi ;
Matsuzaki, Toshihiro ;
Tsutsui, Masato ;
Okamoto, Hiroshi .
VASCULAR PHARMACOLOGY, 2013, 58 (04) :319-325
[15]   Na+/H+ exchange inhibition with HOE642 improves postischemic recovery due to attenuation of Ca2+ overload and prolonged acidosis on reperfusion [J].
Strömer, H ;
de Groot, MCH ;
Horn, M ;
Faul, C ;
Leupold, A ;
Morgan, JP ;
Scholz, W ;
Neubauer, S .
CIRCULATION, 2000, 101 (23) :2749-2755
[16]   Homocysteine induces oxidative, stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin [J].
Topal, G ;
Brunet, A ;
Millanvoye, E ;
Boucher, JL ;
Rendu, F ;
Devynck, MA ;
David-Dufilho, M .
FREE RADICAL BIOLOGY AND MEDICINE, 2004, 36 (12) :1532-1541
[17]  
Tu Jiang-Hua, 2002, Hunan Yike Daxue Xuebao, V27, P13
[18]   Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling [J].
Vacek, Thomas P. ;
Vacek, Jonathan C. ;
Tyagi, Suresh C. .
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2012, 118 (01) :31-42
[19]   Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain [J].
Wang, Shuangxi ;
Peng, Qisheng ;
Zhang, Junhua ;
Liu, Liying .
CARDIOVASCULAR RESEARCH, 2008, 80 (02) :255-262
[20]  
Wang SX, 2005, J CARDIOVASC PHARM, V45, P586